BioCryst Pharmaceuticals Inc (NASDAQ:BCRX)

8.11
Delayed Data
As of Mar 26
 +0.01 / +0.12%
Today’s Change
7.29
Today|||52-Week Range
14.62
-33.31%
Year-to-Date

Today’s Trading

Previous close8.10
Today’s open8.02
Day’s range-- - --
Volume1,328,342
Average volume (3 months)861,152
Market cap$586.5M
Dividend yield--
Data as of 03/26/2015

Growth & Valuation

Earnings growth (last year)-23.64%
Earnings growth (this year)-54.56%
Earnings growth (next 5 years)-14.84%
Revenue growth (last year)-21.48%
P/E ratioNM
Price/Sales59.67
Price/Book--

Competitors

 Today’s
change
Today’s
% change
OSIROsiris Therapeutics ...+0.15+0.87%
FPRXFive Prime Therapeut...+0.03+0.14%
ANIPANI Pharmaceuticals ...+0.05+0.08%
CBMGCellular Biomedicine...-3.43-7.97%
Data as of 03/26/2015

Financials

Next reporting dateMay 8, 2015
EPS forecast (this quarter)-$0.25
Annual revenue (last year)$13.6M
Annual profit (last year)-$45.2M
Net profit margin-332.08%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Jon P. Stonehouse
Chief Financial Officer, Treasurer, CAO &
SVP
Thomas R. Staab
Corporate headquarters
Birmingham, Alabama

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account